VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.
about
Development and Function of Protective and Pathologic Memory CD4 T CellsIntravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract DamageDampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replicationCollateral Damage: Detrimental Effect of Antibiotics on the Development of Protective Immune MemoryTissue-Resident T Cells as the Central Paradigm of Chlamydia ImmunityChlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidatesChlamydia trachomatis Genital Infections.A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell ResponsesConsiderations for the rational design of a Chlamydia vaccineLactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigsImmunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearanceInduction of resident memory T cells enhances the efficacy of cancer vaccineLocal immunization impacts the response of dairy cows to Escherichia coli mastitis.Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract.Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during TuberculosisHuman and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in WomenComparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar DChlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)The multifaceted role of CD4(+) T cells in CD8(+) T cell memoryProgesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential.Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infectionRecombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceHallmarks of Tissue-Resident Lymphocytes.The Chlamydia-Secreted Protease CPAF Promotes Chlamydial Survival in the Mouse Lower Genital TractPhosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatisMucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.Humanized Mouse Models of Clinical Disease.Future prospects for new vaccines against sexually transmitted infections.Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV.CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract.Infection of Hysterectomized Mice with Chlamydia muridarum and Chlamydia trachomatis.Update on Chlamydia trachomatis Vaccinology.Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis.CD103+ lung dendritic cells (LDCs) induce stronger Th1/Th17 immunity to a bacterial lung infection than CD11bhi LDCs.Immunopathogenesis of Chlamydial Infections.Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
P2860
Q26781324-83877715-5D30-45C2-BECD-2AEC66BC0CB3Q27323271-C27F3B65-D747-453F-82BD-B2B8E7D53C02Q27869764-F66E2B45-D324-425D-8360-2BFEAEAF6287Q28066947-F3954EC1-36E1-49B4-8D02-7F62EF5BAFB3Q28075820-4D4CE031-FC7E-4FF6-8422-97780FA48696Q28083729-A0DCA9D9-9AB4-49D5-9B9E-9A36AF3250A9Q30235030-9F3C6543-BD81-42B0-AD47-958371BF231AQ30388522-C254AC72-C009-4EA8-A424-0AA37D84562AQ33601324-62923FD3-96AB-4285-B616-5F9421C85ECDQ33632705-B7ECCF6A-CEDE-45FE-94A7-F46DA62424A3Q33694896-37EAE70B-FD38-4B5F-9CE6-188EE13BF845Q33740057-EF64651D-0009-4F04-841C-410E01818115Q33757880-2EAF7669-6431-4489-8459-512F1DB988BAQ33761198-627862CF-EB15-4640-B457-3FD6CCF0CCB6Q33794078-BA95164B-75FA-4FCA-A895-C92DB5878EC0Q33870372-D8BF226F-3900-4EE3-9345-B5D9A90A5017Q35821088-E7274234-AA28-4D8F-A81D-3601E243AB71Q35855579-386C0C77-E0FB-4E0D-B8AA-315FF80A1B79Q35888761-BE012EE6-E56F-49A2-849A-8474DAA50A84Q35992863-7AE5E20C-CBEA-4093-A26F-C8418CEEECCEQ36053573-4D9473D0-6F3A-46A5-980A-29EB0C4EE519Q36262385-B0E87E81-14AA-4F79-9982-AFF176BC6AD9Q36879974-50D08DC8-3ECD-4185-9981-D4D10879A04EQ37018399-E4710C09-452A-4820-954A-E2E7CFE5CA1CQ37123679-F6E6B19A-FC6D-43E5-9DDB-B50BC7AF03A9Q37140167-C324F2CF-7444-480C-ADA1-D9598CB1E444Q37152701-0CA391CD-8EB6-436D-A764-EC9ABA40C2B3Q37199905-A46C0CBF-BAB6-40D3-9CD2-0AAC6B010822Q37264979-4346ACBA-3430-4FC9-BD61-2E8DD70EA154Q37430524-5D5C44FE-5E26-49E4-B3E2-606DF0273668Q37614202-04977685-BE61-47DE-8040-12E7A60B0D03Q37665012-E58DBBF9-7EF4-4954-8642-BB9307709E56Q37675710-07281C79-98A8-4A96-9314-B15C3B403357Q37833657-ABEC7DF9-AEBC-44E2-8EF8-10F2BD2E4B9CQ37834302-54C6DCD0-A268-4FCE-9CFA-9B4553130BB5Q37834874-363F23E0-E072-49DE-ADEE-E8D9C5324875Q37834944-FF1964CA-A482-403F-96ED-68D32C62DDD0Q37834957-E28FAC83-2E4F-41B9-8984-1441C3EBAD5AQ37836040-6D907F28-3D59-4579-A3DA-4E04B695B1FCQ37837221-3E5B7A6D-276C-4F69-BAEF-264C8415908E
P2860
VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@ast
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@en
type
label
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@ast
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@en
prefLabel
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@ast
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@en
P2093
P2860
P50
P356
P1433
P1476
VACCINES. A mucosal vaccine ag ...... of protective memory T cells.
@en
P2093
Aleksandar F Radovic-Moreno
Andrew M Tager
David Alvarez
David Gondek
Jeremy A Yethon
Jinjun Shi
Mario Perro
Michael N Starnbach
Robert Langer
Ulrich H von Andrian
P2860
P304
P356
10.1126/SCIENCE.AAA8205
P407
P577
2015-06-01T00:00:00Z